Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical comparison of dissolution curves.

R Bartoszynski1, J D Powers, E E Herderick

  • 1Department of Statistics, The Ohio State University, Columbus, 43210, USA.

Pharmacological Research
|May 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Portal Use Near the End-of-Life.

Journal of general internal medicine·2021
Same author

The predicted role of steric specificity in crowding-mediated effects on reversible biomolecular association.

Physical biology·2015
Same author

Predictors of a child's ability to use a visual analogue scale.

Child: care, health and development·2003
Same author

Atherosclerosis in youth.

Minerva pediatrica·2002
Same author

Bioequivalent or nonbioequivalent?

Pharmacological research·2001
Same author

Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis.

Mathematical biosciences·2001
Same journal

GLP-1 Receptor Agonist Therapy in Children and Adolescents with Obesity: A Network Meta-Analysis of Differential Cardiometabolic Efficacy and Safety Profiles.

Pharmacological research·2026
Same journal

Sinomenine regulates the AKT/FOXO3/GLUL pathway to inhibit pulmonary fibroblast-to-myofibroblast transition via α7nAChR against rheumatoid arthritis associated interstitial lung disease.

Pharmacological research·2026
Same journal

Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.

Pharmacological research·2026
Same journal

GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies.

Pharmacological research·2026
Same journal

Cajaninstilbene acid in macrophage immunometabolism and angiogenesis: Mechanisms and therapeutic potential.

Pharmacological research·2026
Same journal

From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal Pain.

Pharmacological research·2026
See all related articles

This study introduces novel statistical methods to compare dissolution curves, offering a more robust alternative to the FDA

Area of Science:

  • Pharmaceutical Sciences
  • Biostatistics
  • Drug Development

Background:

  • Current methods for comparing dissolution profiles, like the FDA's f(2) statistic, have limitations.
  • Existing procedures often overlook intra-set variability, leading to potentially inaccurate similarity conclusions.
  • The FDA's current approach focuses on mean curves, ignoring crucial data variability.

Purpose of the Study:

  • To develop advanced statistical procedures for assessing the similarity of two sets of dissolution curves.
  • To provide more statistically sound methods than the current FDA approach for dissolution profile analysis.
  • To introduce new statistical tools that account for variability within dissolution profile datasets.

Main Methods:

  • Developed three novel statistical methods for comparing dissolution curves.

Related Experiment Videos

  • Extended the Mann-Whitney test to incorporate intra-set and inter-set variability.
  • Adapted the Kolmogorov-Smirnov D statistic and the chi-squared test for dissolution profile comparison.
  • Created a computer program to implement these algorithms for various sample sizes.

    • Main Results:

    • The proposed statistics offer a more comprehensive comparison of dissolution curves.
    • These methods provide improved statistical rigor over existing FDA procedures.
    • Decision rules and power functions were developed for the new statistical tests.

    Conclusions:

    • The developed statistical procedures provide a more accurate and reliable assessment of dissolution curve similarity.
    • These advanced methods address the limitations of current FDA practices by incorporating variability.
    • The availability of a computer program facilitates the practical application of these enhanced statistical tools in pharmaceutical research.